Vous êtes sur la page 1sur 10

Deakin University CRICOS Provider Code: 00113B

Infuenza virus research and funding opportunities


GCEID WORKSHOP!I"KI"G IDE#S $O OPPOR$%"I$IES
#&PRO'( )OH" S$#*+#S
SCHOO! O' *EDICI"E
,
$H
)%!- ./0,
Deakin University CRICOS Provider Code: 00113B
S$RE"G$HS1 C#P#+I!I$IES #"D E2PER$ISE
#ni3a4 3ode4s of infuenza virus infection 5CSIRO ##H!&Dea6in %niversit78

'erret

Chic6en

Duc6

*ouse

Pigs
C4inica4&$rans4ationa4 5+ar9on Hea4th8

C4inica4 tria4 e:perience

#ccess to hu3an c4inica4 sa3p4es


Wi4d4ife Eco4og7&Survei44ance 5Dea6in&CSIRO ##H!8

+ird 3igration and disease eco4og7


Pathogenesis1 I33unit7 and therapeutics 5CSIRO ##H!&Dea6in8

;iro4og7&Histo4og7

Innate and adaptive i33unit7


Deakin University CRICOS Provider Code: 00113B
Infrastructure

PC< ani3a4 faci4ities

PC< 4a=oratories

PC< #RC !IE'&"CRIS funded I33uno4og7&fo9 faci4it7 4a=orator7

PC. 4a=oratories
Co44a=orations

'edera4 and State Govern3ents

WHO

'#O

"H*RC Infuenza Progra3 Grant >#nne Ke4so

"IH&"I#ID Centers of E:ce44ence for Infuenza Research and Survei44ance 5CEIRS8


E3or7&%niversit7 of Georgia and St )ude Chi4dren?s Research Hospita4
Deakin University CRICOS Provider Code: 00113B
Each "I#ID Center of E:ce44ence for Infuenza Research and Survei44ance has a focus on one or =oth of
the fo44o9ing research areas@
Research #rea 0@ #ni3a4 Infuenza Survei44ance Conduct prospective internationa4 and&or do3estic
ani3a4 infuenza survei44ance for the rapid detection and characterization of infuenza viruses 9ith
pande3ic potentia4(
Research #rea .@ Pathogenesis and Host Response Research Conduct research to enhance
understanding of the 3o4ecu4ar1 eco4ogica41 and&or environ3enta4 factors that infuence pathogenesis1
trans3ission1 and evo4ution of infuenza virusesA and characterize the protective i33une response(
http://www.niaid.nih.gov/labsandresources/resources/ceirs/Pages/introduction.aspx
Deakin University CRICOS Provider Code: 00113B
WHERE $O 'RO* HEREB
Realistically a 3-5 year process
Deakin University CRICOS Provider Code: 00113B
0( Cosupervise PhD&Honours students 5Dea6in&CSIRO ##H!8
.( Deve4op funda=4e ideas and generate pre4i3inar7 data
<( I3prove our trac6 records
,( #pp47 fro3 s3a44 grants i(e universit7 grants
C( #pp47 for "ationa447 Co3petitive grant sche3es i(e "H*RC1 #RC
D( #pp47 for Internationa4 grants
Ho9 do 9e get thereB
Deakin University CRICOS Provider Code: 00113B
0( Generation of transgenic&6noc6out ani3a4s to stud7 infection in host species
using geno3e editing e(g E'"s1 $#!E"S1 CRISPR
.( *iR"#s 5virus&host e:pressedA de4iver78
<( $herapeutics e(g I'"
,( Characterisation and 3odu4ation of overactive host i33une responses
C( Reagent deve4op3ent
D( Deep seFuencing&+ioinfor3atics
G( Enhanced vaccine ce44 4ines
#reas of deve4oping research and InnovationB
Deakin University CRICOS Provider Code: 00113B
"H*RC
"H*RC ProHect grants
"H*RC $argeted and %rgent Ca44s@ One oI grant sche3esA HC"0 and H0"0
"H*RC Deve4op3ent #9ards@ Industr7 partners reFuired
NHMRC Program Grants
NHMRC Centres for Research Excellence
NHMRC Fellowships
#RC
#RC DECR#@ Ear47 Career fe44o9ship
#RC Discover7 ProHects
#RC !in6age grants@ Industr7 partners reFuired
#RC !IE'
ARC Future Fellowships
'unding OpportunitiesDo3estic
Deakin University CRICOS Provider Code: 00113B
"IH Deve4op3ent of "ove4 $herapeutics for Se4ect Pathogens > Octo=er
.01 ./0, 5!OI Sept 0J8
+asic to trans4ationa4 research focused on deve4op3ent of nove4 therapeutics against
se4ect anti=ioticresistant gra3negative =acteria or infuenza
IdentiKcation and va4idation of@

ne9 vira4 or host targets for drug discover7

s3a44 3o4ecu4e inhi=itors directed at vira4 or host targets

hostdirected co3pounds that 3odu4ate i33une response

4i=rar7 screening

in vitro or in vivo 3ode4s

prec4inica4 characterization of candidate therapeutics


'unding OpportunitiesInternationa4
Slide courtesy of J. Lowenthal, CS!" ##$L
Deakin University CRICOS Provider Code: 00113B
"I#ID@$argeting $herapeutics Deve4op3ent to Re4ieve +ott4enec6s #ugust 0<1 ./0,

+road spectru3 antivira4

Hostdirected =road spectru3 therapeutic

$herapeutic 9ith activit7 against 3ore than one of the "I#ID Categor7 #1 + and C vira4 threat agent
#"D inc4uding activit7 against at 4east one of the fo44o9ing vira4 pathogens@
E=o4a virus1 *ar=urg virus1 Dengue virus1 Chi6ungun7a virus and Hu3an infuenza virus(
'unding OpportunitiesInternationa4
Slide courtesy of J. Lowenthal, CS!" ##$L

Vous aimerez peut-être aussi